HAI Diagnostic and Testing Markets Show 3 Percent Growth
A new market research report from Kalorama Information, "Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends," says that diagnostics and treatment segments taken together are valued at more than $9 billion for 2010 with 2015 sales expected to reach $10.3 billion.
The market has grown by 3 percent year-on-year, with sales increasing from $7.9 billion in 2005. With the treatment segment struggling to maintain growth, the testing segment is likely to offset declines starting in 2012.
Understanding Infection Risks for Patients With Diabetes During Diabetes Awareness Month
November 30th 2023Diabetes Awareness Month in November highlights the heightened susceptibility of diabetes patients to infections. Explore the key reasons behind their increased infection risk and the importance of infection prevention.
